Clinical trial
Effects of Atorvastatin on Myonecrosis
NCT00344019 · Beth Israel Deaconess Medical Center, Other · Terminated
Key facts
| NCT number | NCT00344019 |
|---|---|
| Title | Effects of Atorvastatin on Myonecrosis |
| Official title | Effects of Single-Dose Atorvastatin on Peri-Procedural Myonecrosis During Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes - The NO-MI Study |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | Pfizer Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Drug, Other |
| Interventions | Placebo Oral Tablet, Atorvastatin 80mg, Screening |
| Enrollment | 97 |
| Start date | May 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Jun 26, 2006 |
| Last update posted | Jan 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: